Skip Navigation

European Heart Journal 2001 22(7):534-540; doi:10.1053/euhj.2001.2613
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yacoub, M.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yacoub, M.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical Perspectives

A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery

M.H. Yacoubf1

Heart Science Centre, Royal Brompton and Harefield Hospital, Harefield, Middlesex, U.K.

Received January 17, 2001;

f1 Correspondence: Sir Magdi H. Yacoub FRS, Professor of Cardiothoracic Surgery, Heart Science Centre, Imperial College of Science Technology & Medicine, Harefield, Middlesex UB9 6JH, U.K.

References

  1. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1992;121:951–957
  2. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601[Free Full Text]
  3. Frazier OH, Benedict CR, Radovacevic B. Improved left ventricular function after chronic ventricular unloading. Ann Thorac Surg. 1996;62:7675–7682
  4. Hetzer R, Muller J, Weng Y, Wallukat G, Siegelsberger S, Loebe. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg. 1999;68:742–749[Abstract/Free Full Text]
  5. Sun BC, Catanese KA, Spanier TB. 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg. 1999;68:688–694[Abstract/Free Full Text]
  6. Mancini DM, Beniamovitz A, Levin H. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998;98:2383–2389[Abstract/Free Full Text]
  7. Katz AM. Cardiomyopathy of overload, a major development of prognosis in congestive heart failure. N Engl J Med. 1990;222:100–110
  8. Lorell BH, Carabello BA. Left ventricular hypertrophy pathogenesis, detection and prognosis. Circulation. 2000;102:470–479[Free Full Text]
  9. Swynghedauw B. Molecular mechanisms of myocardial remodelling. Physiol Rev. 1999;79:216–261
  10. Francis GS. Changing the remodelling process in heart failure. Basic mechanisms and laboratory results. Curr Opin in Cardiol. 1998;13:156–161
  11. Hunter JJ, Chien KR. Signalling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341:1276–1283[Free Full Text]
  12. Sugden PH. Signaling in myocardial hypertrophy. Circ Res. 1999;84:633–646[Free Full Text]
  13. Onodera T, Tamura T, Said S, McCune SA, Gerdes AM. Maladaptive remodelling of cardiac myocyte shape begins long before failure in hypertension. Hypertension. 1998;32:753–757[Abstract/Free Full Text]
  14. Gerdes AM, Tamura T, Wang X. Myocyte remodelling during the progression to failure in rats with hypertension. Hypertension. 1996;28:609–614[Abstract/Free Full Text]
  15. Gerdes AM, Moore JA, Kellerman SE, Clark LC, Schocker DD. Similar change in cardiac myocyte shape in patients with ischaemic and dilated cardiomyopathy (Abstr). Circulation. 1992;86:1–425[Abstract/Free Full Text]
  16. Gerdes AM, Capasso JM. Structural remodelling and mechanical dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol. 1995;27:849–856[CrossRef][ISI][Medline]
  17. Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998;18:656–662
  18. Tamura T, Said S, Harris J, Lu W, Gerdes AM. Reverse remodelling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation. 2000;102:253–259[Abstract/Free Full Text]
  19. Wong K, Boheler KR, Bishop J, Petrou M, Yacoub MH. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc Research. 1998;37:115–122[Abstract/Free Full Text]
  20. Wong K, Boheler KR, Petrou M, Yacoub MH. Pharmacological modulation pressure overload cardiac hypertrophy changes in ventricular function, extracellular matrix, and gene expression. Circulation. 1997;96:2239–2246[Abstract/Free Full Text]
  21. Petrou M, Wynne DG, Boheler KR, Yacoub MH. Clenbuterol induces hypertrophy of the latimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation. 1995;92:II-483–II-489
  22. Houser SR, Lakatta EG. Function of the cardiac myocyte in the conundrum of end-stage, dilated human heart failure. Circulation. 1999;341:1276–1283
  23. Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation. 1995;92:2540–2549[Abstract/Free Full Text]
  24. Ginsburg R, Bristow H, Billingham ME, Stinson EB, Schroeder J, Harrison DC. Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. Am Heart J. 1983;106:535–540[CrossRef][ISI][Medline]
  25. Chien KR. Stress pathways and heart failure. Cell. 1999;98:555–558[CrossRef][ISI][Medline]
  26. Schneider MD, Schwartz RJ. Chips ahoy: gene expression in hearts surveyed by high-density microarrays. Circulation. 2000;102:3020–3027
  27. Corbett JM, Why HJ, Wheeler CH. Cardiac protein abnormalities in cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1998;19:2031–2042[CrossRef][ISI][Medline]
  28. Latif N, Khan M, Birks E. Upregulation of the Bcl-2 family of proteins in end-stage heart failure. J Am Coll Cardiol. 2000;35:1769–1777[Abstract/Free Full Text]
  29. Graham RM, Owens WA. Pathogenesis of inherited forms of dilated cardiomyopathy. N Engl J Med. 1999;341:1759[Free Full Text]
  30. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Knowlton KU. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med. 1999;5:320–326[CrossRef][ISI][Medline]
  31. Brown S, McGrath MJ, Ooms LM. Characterisation of two isoforms of the skeletal muscle LIM protein 1, SLIM1: localisation of SLIM1 at focal adhesions and the isoform slimmer in the nucleus of myoblasts and cytoplasm of myotubes suggests distinct roles in the cytoskeleton and in nuclear-cytoplasmic communication. J Biol Chem. 1999;274:27083–27091[Abstract/Free Full Text]
  32. Arber S, Hunter JJ, Ross J Jr.. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organisation, dilated cardiomyopathy, and heart failure. Cell. 1997;88:393–403[CrossRef][ISI][Medline]
  33. Zolk O, Caroni P, Bohm M. Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation. 2000;101:2674–2677[Abstract/Free Full Text]
  34. Minamisawa S, Hoshijima M, Chu G. Chronic phospholamban sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell. 1999;99:313–322[CrossRef][ISI][Medline]
  35. Spinale FG, Coker ML, Thomas CV, Walker JD, Mukherjee R, Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res. 1998;82:482–495[Abstract/Free Full Text]
  36. Mann DL, Spinale FG. Activation of matrix metalloproteinases in the failing human heart. Breaking the tie that binds. Editorial. Circulation. 1998;98:1699–1702[Free Full Text]
  37. Weber KT. Targeting pathological remodelling: concepts of cardioprotection and reparation. Circulation. 2000;102:1342–1345[Free Full Text]
  38. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation. 2000;102:1388–1393[Abstract/Free Full Text]
  39. Hafizi S, Wharton J, Morgan K. Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts. Circulation. 1998;98:2553–2559[Abstract/Free Full Text]
  40. Starling G. ACE inhibition in cardiovascular disease. N Engl J Med. 2000;342:201–203[Free Full Text]
  41. Pitt B. Regression of left ventricular hypertrophy in patients with hypertension. Blockade of the renin-angiotensin-aldosterone system. Circulation. 1998;98:1987–1989[Free Full Text]
  42. Cohn JN, Levine TB, Olivari MT. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–823[Abstract]
  43. Birks EJ, Yacoub MH. The role of nitric oxide and cytokines in heart failure. Cor Art Dis. 1997;8:389–402
  44. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201–1206[Abstract]
  45. Bristow NR. Beta-adrenergic receptor in chronic heart failure. Circulation. 2000;101:558–569[Free Full Text]
  46. Zaugg M, Xu W, Lucchinetti E, Shafig SA, Gamali NZ, Siddiqui MAQ. Beta-adrenergic subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation. 2000;102:344[Abstract/Free Full Text]
  47. Liggett SB, Tepe NM, Lorenz JN. Early and delayed consequences of beta-adrenergic receptor overexpression in mouse hearts. Critical role for expression level. Circulation. 2000;101:1707–1714[Abstract/Free Full Text]
  48. Frantz S, Kobzik L, Kim YD. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 1999;104:271–280[ISI][Medline]
  49. Wiese S, Breyer T, Dragu A. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation. 2000;102:3074–3079[Abstract/Free Full Text]
  50. McKelvie RS, Yusuf S, Pericak D. Comparison of Candesartan, Enalapril and their combination in congestive heart failure randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) Pilot study: The RESOLVD Pilot. Circulation. 1999;100:1056–1064[Abstract/Free Full Text]
  51. Boateng SY, Seymour AL, Bhutta NS, Dunn MJ, Yacoub MH, Boheler KR. Sub-anti-hypertensive doses of ramipril normalise sarcoplasmic reticulum calcium ATPase expression and function following cardiac hypertrophy in rats. J Mol Cell Cardiol. 1998;30:2683–2694[CrossRef][ISI][Medline]
  52. Pitt B, Zannand F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709–717[Abstract/Free Full Text]
  53. Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Circulation. 2000;102:2700–2706[Abstract/Free Full Text]
  54. Francis DP, Shamin W, Davies LC. Cardiopulmonary exercise testing for prognosis in chronic heart failure continuous and independent prognostic value from VE/VCO2slope and peak VO2. Eur Heart J. 2000;21:154–161[Abstract/Free Full Text]
  55. Birks EJ, Latif N, Bowles C. Measurement of cytokine levels and activation of the apoptotic pathway in patients requiring Left Ventricular Assist Devices (LVAD): implications for timing of implantation. Circulation. 2000;102:II-818
  56. Owen VJ, Burton PB, Michel MC. Myocardial dysfunction in donor hearts. A possible etiology. Circulation. 1999;99:2565–2570[Abstract/Free Full Text]
  57. Birks EJ, Burton PB, Owen V. Elevated tumour necrosis factor-alpha and interluekin-6 in myocardium and serum of malfunctioning donor hearts. Circulation. 2000;102:III352–8
  58. Birks EJ, Yacoub MH, Burton P. Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts. Transplantation. 2000;70:1498–1506[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev, April 1, 2008; 88(2): 729 - 767.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. K.R. Soppa, J. Lee, M. A. Stagg, L. E. Felkin, P. J.R. Barton, U. Siedlecka, S. Youssef, M. H. Yacoub, and C. M.N. Terracciano
Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure
Cardiovasc Res, March 1, 2008; 77(4): 695 - 706.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
I. George and M. C. Oz
Myocardial Revascularization after Acute Myocardial Infarction
Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696.
[Full Text]

Home page
 CirculationHome page
S. Maybaum, D. Mancini, S. Xydas, R. C. Starling, K. Aaronson, F. D. Pagani, L. W. Miller, K. Margulies, S. McRee, O.H. Frazier, et al.
Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group
Circulation, May 15, 2007; 115(19): 2497 - 2505.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. S. George, E. J. Birks, R. C. Radley-Smith, A. Khaghani, and M. Yacoub
Bridge to Transplantation With a Left Ventricular Assist Device for Systemic Ventricular Failure After Mustard Procedure
Ann. Thorac. Surg., January 1, 2007; 83(1): 306 - 308.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
E. J. Birks, P. D. Tansley, J. Hardy, R. S. George, C. T. Bowles, M. Burke, N. R. Banner, A. Khaghani, and M. H. Yacoub
Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure
N. Engl. J. Med., November 2, 2006; 355(18): 1873 - 1884.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
J. G. Burniston, L.-B. Tan, and D. F. Goldspink
Relative myotoxic and haemodynamic effects of the {beta}-agonists fenoterol and clenbuterol measured in conscious unrestrained rats
Exp Physiol, November 1, 2006; 91(6): 1041 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. M. Haj-Yahia, E. J. Birks, J. Hardy, M. H. Yacoub, and A. Khaghani
Minimally invasive technique for explantation of right ventricular assist devices.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1547 - 1548.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. E. Cullen, A. H.Y. Yuen, L. E. Felkin, R. T. Smolenski, J. L. Hall, S. Grindle, L. W. Miller, E. J. Birks, M. H. Yacoub, and P. J.R. Barton
Myocardial Expression of the Arginine:Glycine Amidinotransferase Gene Is Elevated in Heart Failure and Normalized After Recovery: Potential Implications for Local Creatine Synthesis
Circulation, July 4, 2006; 114(1_suppl): I-16 - I-20.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. Matsumiya, O. Monta, N. Fukushima, Y. Sawa, T. Funatsu, K. Toda, and H. Matsuda
Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 699 - 704.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. J. R. Barton, L. E. Felkin, E. J. Birks, M. E. Cullen, N. R. Banner, S. Grindle, J. L. Hall, L. W. Miller, and M. H. Yacoub
Myocardial Insulin-Like Growth Factor-I Gene Expression During Recovery From Heart Failure After Combined Left Ventricular Assist Device and Clenbuterol Therapy
Circulation, August 30, 2005; 112(9_suppl): I-46 - I-50.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. J. Birks, J. L. Hall, P. J.R. Barton, S. Grindle, N. Latif, J. P. Hardy, J. E. Rider, N. R. Banner, A. Khaghani, L. W. Miller, et al.
Gene Profiling Changes in Cytoskeletal Proteins During Clinical Recovery After Left Ventricular-Assist Device Support
Circulation, August 30, 2005; 112(9_suppl): I-57 - I-64.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. G. Burniston, L.-B. Tan, and D. F. Goldspink
{beta}2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle
J Appl Physiol, April 1, 2005; 98(4): 1379 - 1386.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. K. R. Soppa, R. T. Smolenski, N. Latif, A. H. Y. Yuen, A. Malik, J. Karbowska, Z. Kochan, C. M. N. Terracciano, and M. H. Yacoub
Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1468 - H1476.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C.M.N. Terracciano, J. Hardy, E.J. Birks, A. Khaghani, N.R. Banner, and M.H. Yacoub
Clinical Recovery From End-Stage Heart Failure Using Left-Ventricular Assist Device and Pharmacological Therapy Correlates With Increased Sarcoplasmic Reticulum Calcium Content but Not With Regression of Cellular Hypertrophy
Circulation, May 18, 2004; 109(19): 2263 - 2265.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Murtuza, K. Suzuki, G. Bou-Gharios, J. R. Beauchamp, R. T. Smolenski, T. A. Partridge, and M. H. Yacoub
Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium
PNAS, March 23, 2004; 101(12): 4216 - 4221.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
O.H. Frazier and R. M. Delgado
Mechanical Circulatory Support for Advanced Heart Failure: Where Does It Stand in 2003?
Circulation, December 23, 2003; 108(25): 3064 - 3068.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
C. M.N Terracciano, S. E Harding, D. Adamson, M. Koban, P. Tansley, E. J Birks, P. J.R Barton, and M. H Yacoub
Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy
Eur. Heart J., July 2, 2003; 24(14): 1329 - 1339.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A.K. Hasnat, E. T. van der Velde, J. K.F. Hon, and M. H. Yacoub
Reproducible model of post-infarction left ventricular dysfunction: haemodynamic characterization by conductance catheter
Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 98 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. K. F. Hon and M. H. Yacoub
Bridge to recovery with the use of left ventricular assist device and clenbuterol
Ann. Thorac. Surg., June 1, 2003; 75(90060): S36 - 41.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
D. C. Lee, W. Ting, and M. C. Oz
Myocardial Revascularization after Acute Myocardial Infarction
Card. Surg. Adult, January 1, 2003; 2(2003): 639 - 658.
[Full Text]

Home page
 Card Surg AdultHome page
E. L. Kukuy, M. C. Oz, and Y. Naka
Long-Term Mechanical Circulatory Support
Card. Surg. Adult, January 1, 2003; 2(2003): 1491 - 1506.
[Full Text]

Home page
 CirculationHome page
T. Walther, A. Schubert, V. Falk, C. Binner, C. Walther, N. Doll, A. Fabricius, S. Dhein, J. Gummert, and F. W. Mohr
Left Ventricular Reverse Remodeling After Surgical Therapy for Aortic Stenosis: Correlation to Renin-Angiotensin System Gene Expression
Circulation, September 24, 2002; 106(12_suppl_1): I-23 - I-26.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Tansley and M. Yacoub
Minimally invasive explantation of implantable left ventricular assist devices
J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 189 - 191.
[Full Text] [PDF]

Home page
 CirculationHome page
M. Henein, E. J. Birks, P. D.T. Tansley, C. T. Bowles, and M. H. Yacoub
Temporal and Spatial Changes in Left Ventricular Pattern of Flow During Continuous Assist Device "HeartMate II"
Circulation, May 14, 2002; 105(19): 2324 - 2325.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
N. de Jonge, D. F. van Wichen, M. E. I. Schipper, J. R. Lahpor, F. H. J. Gmelig-Meyling, E. O. Robles de Medina, and R. A. de Weger
Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading: An immunohistochemical analysis of the contractile myofilaments
J. Am. Coll. Cardiol., March 20, 2002; 39(6): 963 - 969.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yacoub, M.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yacoub, M.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?